PER 1.23% 8.0¢ percheron therapeutics limited

Ann: US FDA Type C Meeting for ATL1102 in DMD, page-46

  1. 3,090 Posts.
    lightbulb Created with Sketch. 499
    my vision is for this beast of a drug to get cranking globally asap. if that takes 20M from someone to fund it, so be it. It'll all wash up the same - dillution via sales with partner or dillution via cr. either way the ball rolls, and I expect fast.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.